J. Castilla, P. Saa, C. Hetz, and C. Soto, In vitro generation of infectious scrapie prions, Cell, vol.121, issue.2, pp.195-206, 2005.

N. R. Deleault, B. T. Harris, J. R. Rees, and S. Supattapone, Formation of native prions from minimal components in vitro, Proc Natl Acad Sci U S A, vol.104, issue.23, pp.9741-9747, 2007.

S. B. Prusiner, Novel proteinaceous infectious particles cause scrapie, Science, vol.216, issue.4542, pp.136-180, 1982.

A. Aguzzi, F. Baumann, and J. Bremer, The prion's elusive reason for being, Annu Rev Neurosci, vol.31, pp.439-77, 2008.

K. S. Lee, R. Linden, M. A. Prado, R. R. Brentani, and V. R. Martins, Towards cellular receptors for prions, Rev Med Virol, vol.13, issue.6, pp.399-408, 2003.

R. Linden, V. R. Martins, M. A. Prado, M. Cammarota, I. Izquierdo et al., Physiology of the prion protein, Physiol Rev, vol.88, issue.2, pp.673-728, 2008.

B. Schneider, M. Pietri, E. Pradines, D. Loubet, J. M. Launay et al., Understanding the neurospecificity of Prion protein signaling, Front Biosci, vol.16, pp.169-86, 2011.

N. R. Deleault, D. J. Walsh, J. R. Piro, F. Wang, X. Wang et al., Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions, Proc Natl Acad Sci U S A, vol.109, issue.28, pp.1938-1984, 2012.

J. Ma, The role of cofactors in prion propagation and infectivity, PLoS Pathog, vol.8, issue.4, p.1002589, 2012.

A. Aguzzi, M. Heikenwalder, and M. Polymenidou, Insights into prion strains and neurotoxicity, Nat Rev Mol Cell Biol, vol.8, issue.7, pp.552-61, 2007.

T. Eichner and S. E. Radford, A diversity of assembly mechanisms of a generic amyloid fold, Mol Cell, vol.43, issue.1, pp.8-18, 2011.

D. Hicks, D. John, N. Z. Makova, Z. Henderson, N. N. Nalivaeva et al., Membrane targeting, shedding and protein interactions of brain acetylcholinesterase, J Neurochem, vol.116, issue.5, pp.742-748, 2011.

H. Q. Xie, D. Liang, K. W. Leung, V. P. Chen, K. Y. Zhu et al., Targeting acetylcholinesterase to membrane rafts: a function mediated by the proline-rich membrane anchor (PRiMA) in neurons, J Biol Chem, vol.285, issue.15, pp.11537-11583, 2010.

P. G. Layer, Nonclassical roles of cholinesterases in the embryonic brain and possible links to Alzheimer disease, Alzheimer Dis Assoc Disord, vol.9, issue.2, pp.29-36, 1995.

I. Silman and J. L. Sussman, Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology, Curr Opin Pharmacol, vol.5, issue.3, pp.293-302, 2005.

S. A. Greenfield, M. Zimmermann, and C. E. Bond, Non-hydrolytic functions of acetylcholinesterase. The significance of C-terminal peptides, FEBS J, vol.275, issue.4, pp.604-615, 2008.

H. Soreq and S. Seidman, Acetylcholinesterase-new roles for an old actor, Nat Rev Neurosci, vol.2, issue.4, pp.294-302, 2001.

M. C. Dinamarca, J. P. Sagal, R. A. Quintanilla, J. A. Godoy, M. S. Arrazola et al., Amyloid-beta-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease, Mol Neurodegener, vol.5, p.4, 2010.

N. C. Inestrosa, M. C. Dinamarca, and A. Alvarez, Amyloid-cholinesterase interactions. Implications for Alzheimer's disease, FEBS J, vol.275, issue.4, pp.625-657, 2008.

A. E. Reyes, M. A. Chacon, M. C. Dinamarca, W. Cerpa, C. Morgan et al., Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss, Am J Pathol, vol.164, issue.6, pp.2163-74, 2004.

T. Rees, P. I. Hammond, H. Soreq, S. Younkin, and S. Brimijoin, Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex, Neurobiol Aging, vol.24, issue.6, pp.777-87, 2003.

T. M. Rees, A. Berson, E. H. Sklan, L. Younkin, S. Younkin et al., Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice, Curr Alzheimer Res, vol.2, issue.3, pp.291-300, 2005.

D. Ferrari, G. V. Canales, M. A. Shin, I. Weiner, L. M. Silman et al., A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation, Biochemistry, vol.40, issue.35, pp.10447-57, 2001.

J. L. Sussman, M. Harel, F. Frolow, C. Oefner, A. Goldman et al., Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein, Science, vol.253, issue.5022, pp.872-881, 1991.

P. Taylor and S. Lappi, Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding, Biochemistry, vol.14, issue.9, pp.1989-97, 1975.

A. Castro and A. Martinez, Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors, Curr Pharm Des, vol.12, issue.33, pp.4377-87, 2006.

U. Holzgrabe, P. Kapkova, V. Alptuzun, J. Scheiber, and E. Kugelmann, Targeting acetylcholinesterase to treat neurodegeneration, Expert Opin Ther Targets, vol.11, issue.2, pp.161-79, 2007.

D. Munoz-torrero, Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease, Curr Med Chem, vol.15, issue.24, pp.2433-55, 2008.

A. Rampa, F. Belluti, S. Gobbi, and A. Bisi, Hybrid-based multi-target ligands for the treatment of Alzheimer's disease, Curr Top Med Chem, vol.11, issue.22, pp.2716-2746, 2011.

M. Pera, A. Martinez-otero, L. Colombo, M. Salmona, D. Ruiz-molina et al., Acetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process, Mol Cell Neurosci, vol.40, issue.2, pp.217-241, 2009.

M. Pera, S. Roman, M. Ratia, P. Camps, D. Munoz-torrero et al., Acetylcholinesterase triggers the aggregation of PrP 106-126, Biochem Biophys Res Commun, vol.346, issue.1, pp.89-94, 2006.

M. X. Silveyra, N. Cuadrado-corrales, M. A. Barquero, M. S. Rabano, A. Calero et al., Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease, J Neurochem, vol.96, issue.1, pp.97-104, 2006.

M. X. Silveyra, M. S. Garcia-ayllon, M. Calero, and J. Saez-valero, Altered glycosylation of acetylcholinesterase in the Creutzfeldt-Jakob cerebrospinal fluid, J Mol Neurosci: MN, vol.30, issue.1-2, pp.65-71, 2006.

H. Rezaei, D. Marc, Y. Choiset, M. Takahashi, H. Bon-hoa et al., High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility, Eur J Biochem/FEBS, vol.267, issue.10, pp.2833-2842, 2000.

E. Carletti, H. Li, B. Li, F. Ekstrom, Y. Nicolet et al., Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation, J Am Chem Soc, vol.130, issue.47, pp.16011-16031, 2008.

P. Camps, J. Contreras, M. Font-bardia, J. Morral, D. Munoz-torrero et al., Enantioselective synthesis of tacrine ? huperzine A hybrids. Preparative chiral MPLC separation of their racemic mixtures and absolute configuration assignments by X-ray diffraction analysis, Tetrahedron Asymmetry, vol.9, issue.9, pp.835-884, 1998.

P. Camps, X. Formosa, D. Munoz-torrero, J. Petrignet, A. Badia et al., Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors, J Med Chem, vol.48, issue.6, pp.1701-1705, 2005.

F. Archer, C. Bachelin, O. Andreoletti, N. Besnard, G. Perrot et al., Cultured peripheral neuroglial cells are highly permissive to sheep prion infection, J Virol, vol.78, issue.1, pp.482-90, 2004.

D. Vilette, O. Andreoletti, F. Archer, M. F. Madelaine, J. L. Vilotte et al., Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein, Proc Natl Acad Sci U S A, vol.98, issue.7, pp.4055-4064, 2001.

C. Feraudet, N. Morel, S. Simon, H. Volland, Y. Frobert et al., Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells, J Biol Chem, vol.280, issue.12, pp.11247-58, 2005.

L. L. Jennings, M. Malecki, E. A. Komives, and P. Taylor, Direct analysis of the kinetic profiles of organophosphate-acetylcholinesterase adducts by MALDI-TOF mass spectrometry, Biochemistry, vol.42, issue.37, pp.11083-91, 2003.

L. Breydo, N. Makarava, and I. V. Baskakov, Methods for conversion of prion protein into amyloid fibrils, Methods Mol Biol, vol.459, pp.105-120, 2008.

O. V. Bocharova, N. Makarava, L. Breydo, M. Anderson, V. V. Salnikov et al., Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core, J Biol Chem, vol.281, issue.4, pp.2373-2382, 2006.

D. El-moustaine, V. Perrier, A. Van-ba, I. Meersman, F. Ostapchenko et al., Amyloid features and neuronal toxicity of mature prion fibrils are highly sensitive to high pressure, J Biol Chem, vol.286, issue.15, pp.13448-59, 2011.

P. Tixador, L. Herzog, R. F. Jaumain, E. Chapuis, J. et al., The physical relationship between infectivity and prion protein aggregates is strain-dependent, PLoS Pathog, vol.6, issue.4, p.1000859, 2010.

V. Beringue, O. Andreoletti, L. Dur, A. Essalmani, R. Vilotte et al., A bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like phenotype on interspecies transmission, 2007.

, J Neurosci: Offic J Soc Neurosci, vol.27, issue.26, pp.6965-71

N. Oumata, P. H. Nguyen, V. Beringue, F. Soubigou, Y. Pang et al., The toll-like receptor agonist imiquimod is active against prions, PLoS One, vol.8, issue.8, p.72112, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02122382

D. Tribouillard-tanvier, V. Beringue, N. Desban, F. Gug, S. Bach et al., Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions, PLoS One, vol.3, issue.4, p.1981, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00416056

P. Camps, R. El-achab, J. Morral, D. Munoz-torrero, A. Badia et al., New tacrine-huperzine A hybrids (huprines): highly potent tightbinding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease, J Med Chem, vol.43, issue.24, pp.4657-66, 2000.

H. Rezaei, Y. Choiset, F. Eghiaian, E. Treguer, P. Mentre et al., Amyloidogenic unfolding intermediates differentiate sheep prion protein variants, J Mol Biol, vol.322, issue.4, pp.799-814, 2002.

I. V. Baskakov, G. Legname, M. A. Baldwin, S. B. Prusiner, and F. E. Cohen, Pathway complexity of prion protein assembly into amyloid, J Biol Chem, vol.277, issue.24, pp.21140-21148, 2002.

J. Espallergues, L. Galvan, F. Sabatier, V. Rana-poussine, M. T. Chatonnet et al., Behavioral phenotyping of heterozygous acetylcholinesterase knockout (AChE+/?) mice showed no memory enhancement but hyposensitivity to amnesic drugs, Behav Brain Res, vol.206, issue.2, pp.263-73, 2010.

J. Collinge, Prion diseases of humans and animals: their causes and molecular basis, Annu Rev Neurosci, vol.24, pp.519-50, 2001.

S. B. Prusiner, Prions. Proc Natl Acad Sci U S A, vol.95, issue.23, pp.13363-83, 1998.

N. Makarava, G. G. Kovacs, O. Bocharova, R. Savtchenko, I. Alexeeva et al., Recombinant prion protein induces a new transmissible prion disease in wild-type animals, Acta Neuropathol, vol.119, issue.2, pp.177-87, 2010.

Z. Zhang, Y. Zhang, F. Wang, X. Wang, Y. Xu et al., De novo generation of infectious prions with bacterially expressed recombinant prion protein, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013.

E. G. Duysen, B. Li, W. Xie, L. M. Schopfer, R. S. Anderson et al., Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality, J Pharmacol Exp Ther, vol.299, issue.2, pp.528-563, 2001.

R. A. Moore, A. Timmes, P. A. Wilmarth, and S. A. Priola, Comparative profiling of highly enriched 22 L and Chandler mouse scrapie prion protein preparations, Proteomics, vol.10, issue.15, pp.2858-69, 2010.

C. Galdeano, E. Viayna, I. Sola, X. Formosa, P. Camps et al., Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases, J Med Chem, vol.55, issue.2, pp.661-670, 2012.

N. J. Cobb, F. D. Sonnichsen, H. Mchaourab, and W. K. Surewicz, Molecular architecture of human prion protein amyloid: a parallel, in-register betastructure, Proc Natl Acad Sci U S A, vol.104, issue.48, pp.18946-51, 2007.

X. Lu, P. L. Wintrode, and W. K. Surewicz, Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange, Proc Natl Acad Sci U S A, vol.104, issue.5, pp.1510-1515, 2007.

N. Makarava and I. V. Baskakov, The same primary structure of the prion protein yields two distinct self-propagating states, J Biol Chem, vol.283, issue.23, pp.15988-96, 2008.

V. G. Ostapchenko, M. R. Sawaya, N. Makarava, R. Savtchenko, K. P. Nilsson et al., Two amyloid States of the prion protein display significantly different folding patterns, J Mol Biol, vol.400, issue.4, pp.908-929, 2010.

R. Tycko, R. Savtchenko, V. G. Ostapchenko, N. Makarava, and I. V. Baskakov, The alpha-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel beta-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance, Biochemistry, vol.49, issue.44, pp.9488-97, 2010.

H. Dvir, I. Silman, M. Harel, T. L. Rosenberry, and J. L. Sussman, Acetylcholinesterase: from 3D structure to function, Chem Biol Interact, vol.187, issue.1-3, pp.10-22, 2010.

V. Beringue, L. Herzog, E. Jaumain, R. F. Sibille, P. et al., Facilitated cross-species transmission of prions in extraneural tissue, Science, vol.335, issue.6067, pp.472-477, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01019814

G. Mcgovern and M. Jeffrey, Scrapie-specific pathology of sheep lymphoid tissues, PLoS One, vol.2, issue.12, p.1304, 2007.

D. L. Bellinger, D. Lorton, R. W. Hamill, S. Y. Felten, and D. L. Felten, Acetylcholinesterase staining and choline acetyltransferase activity in the young adult rat spleen: lack of evidence for cholinergic innervation, Brain Behav Immun, vol.7, issue.3, pp.191-204, 1993.

I. A. Lampert and S. Van-noorden, Acetyl cholinesterase is expressed in the follicular dendritic cells of germinal centres: differences between normal and neoplastic follicles, J Pathol, vol.180, issue.2, pp.169-74, 1996.

M. Dron, M. Moudjou, J. Chapuis, M. K. Salamat, J. Bernard et al., Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell-and tissue-dependent, J Biol Chem, vol.285, issue.14, pp.10252-64, 2010.

J. Lauren, D. A. Gimbel, H. B. Nygaard, J. W. Gilbert, and S. M. Strittmatter, Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers, Nature, vol.457, issue.7233, pp.1128-1160, 2009.

, Submit your next manuscript to BioMed Central and take full advantage of: ? Convenient online submission ? Thorough peer review ? No space constraints or color figure charges ? Immediate publication on acceptance ? Inclusion in PubMed, CAS, Scopus and Google Scholar ? Research which is freely available for redistribution Submit your manuscript at www